Table 3.
Behaviors and risk factors comparing PLHIV with and without risk of ATI during the COVID‐19 outbreak in China
| Characteristics |
Total (N=5084) n (%) |
No risk of ATI (N=3302) n (%) |
Threatened but resolved risk of ATI (N=730) n (%) |
Risk of imminent ATI (N=917) n (%) |
Experienced ATI (N=135) n (%) |
p value |
|---|---|---|---|---|---|---|
| Previous ATI before COVID‐19 | ||||||
| Yes | 1070 (21.05) | 600 (18.17) | 190 (26.03) | 193 (21.05) | 87 (64.44) | <0.001 |
| No | 4014 (78.95) | 2702 (81.83) | 540 (73.97) | 724 (78.95) | 48 (35.56) | |
| Reason for previous ATI | ||||||
| Could not obtain ART in time | 232 (21.68) | 77 (12.83) | 51 (26.84) | 57 (29.53) | 47 (54.02) | <0.001 |
| Decided to stop ART | 55 (5.14) | 36 (6.00) | 5 (2.63) | 8 (4.15) | 6 (6.90) | 0.230 |
| Intolerable ART side effects | 173 (16.17) | 99 (16.50) | 28 (14.74) | 30 (15.54) | 16 (18.39) | 0.871 |
| Forgot to take ART | 738 (68.97) | 445 (74.17) | 134 (70.53) | 123 (63.73) | 36 (41.38) | <0.001 |
| Village/street/community on lockdown during COVID‐19 | ||||||
| Yes | 3582 (70.46) | 2096 (63.48) | 569 (77.95) | 800 (87.24) | 117 (86.67) | <0.001 |
| No | 1281 (25.20) | 1036 (31.37) | 140 (19.18) | 91 (9.92) | 14 (10.37) | |
| Not sure | 221 (4.35) | 170 (5.15) | 21 (2.88) | 26 (2.84) | 4 (2.96) | |
| Traveled away from site of primary HIV care during COVID‐19 | ||||||
| Yes | 1967 (38.69) | 914 (27.68) | 448 (61.37) | 532 (58.02) | 73 (54.07) | <0.001 |
| No | 3117 (61.31) | 2388 (72.32) | 282 (38.63) | 385 (41.98) | 62 (45.93) | |
| No. days of planned travel a | ||||||
| <15 | 1124 (57.23) | 525 (57.57) | 290 (64.88) | 255 (47.93) | 54 (73.97) | <0.001 |
| 15 to 29 | 500 (25.46) | 191 (20.94) | 113 (25.28) | 182 (34.21) | 14 (19.18) | |
| ≥30 | 340 (17.31) | 196 (21.49) | 44 (9.84) | 95 (17.86) | 5 (6.85) | |
| No. days of pills prepared before travel b | ||||||
| <15 | 378 (19.24) | 179 (19.63) | 122 (27.23) | 49 (9.21) | 28 (38.36) | <0.001 |
| 15 to 29 | 607 (30.89) | 192 (21.05) | 192 (42.86) | 184 (34.59) | 39 (53.42) | |
| ≥30 | 980 (49.87) | 541 (59.32) | 134 (29.91) | 299 (56.20) | 6 (8.22) | |
| Location during CNY 2020 (January 10 to February 17) | ||||||
| Domestic urban area | 2792 (54.92) | 2101 (63.63) | 337 (46.16) | 320 (34.90) | 34 (25.19) | <0.001 |
| Domestic rural area | 1787 (35.15) | 857 (25.95) | 348 (47.67) | 503 (54.85) | 79 (58.52) | |
| Overseas | 132 (2.60) | 95 (2.88) | 19 (2.60) | 14 (1.53) | 4 (2.96) | |
| Unknown c | 373 (7.34) | 249 (7.54) | 26 (3.56) | 80 (8.72) | 18 (13.33) | |
| Perceived risk factors for ATI | ||||||
| Lockdown and travel restrictions | 4235 (83.30) | 2651 (80.28) | 662 (90.68) | 804 (87.68) | 118 (87.41) | <0.001 |
| Insufficient ART supply at HIV clinic or pharmacy | 2402 (47.25) | 1718 (52.03) | 340 (46.58) | 302 (32.93) | 42 (31.11) | <0.001 |
| Suspension of postal and courier services | 2570 (50.55) | 1541 (46.67) | 466 (63.84) | 492 (53.65) | 71 (52.59) | <0.001 |
| Insufficient ART reserve at home | 3630 (71.40) | 2279 (69.02) | 585 (80.14) | 671 (73.17) | 95 (70.37) | <0.001 |
| Borrowed pills from other PLHIV before COVID‐19 | ||||||
| Yes | 136 (58.62) | 39 (50.65) | 40 (78.43) | 32 (56.14) | 25 (53.19) | 0.012 |
| No | 96 (41.38) | 38 (49.35) | 11 (21.57) | 25 (43.86) | 22 (46.81) | |
The bold values are statistically significant (p < 0.05) in Pearson’s Chi squared test. ART, antiretroviral therapy; ATI, antiretroviral therapy interruption; CNY, Chinese New Year; PLHIV, people living with HIV.
a
3 missing
b
2 missing
c
the location cannot be judged based on the information provided, shown as “unknown”, not discussed.